Evidence map›Paper›PMID 37813896›Full record

ArticleNPJ biofilms and microbiomes2023

Digestive exophagy of biofilms by intestinal amoeba and its impact on stress tolerance and cytotoxicity.

Eva Zanditenas, Meirav Trebicz-Geffen, Divya Kolli, Laura Domínguez-García, Einan Farhi, Liat Linde, Diego Romero, Matthew Chapman, Ilana Kolodkin-Gal, Serge Ankri

Open access · goldAbstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Impact of Reactive Sulfur Species onAntioxidants (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Eva ZanditenasDepartment of Molecular Microbiology, Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Meirav Trebicz-GeffenDepartment of Molecular Microbiology, Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Divya Kolli *Department of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, USA.ORCID 0000-0002-4465-065X
Laura Domínguez-García *Departamento de Microbiología, Instituto de Hortofruticultura Subtropical y Mediterránea 'La Mayora', Universidad de Málaga-Consejo Superior de Investigaciones Científicas (IHSM-UMA-CSIC), Universidad de Málaga, Málaga, Spain.ORCID 0009-0003-6164-4475
Einan FarhiTechnion Genomics Center, Technion - Israel Institute of Technology, Haifa, Israel.
Liat LindeTechnion Genomics Center, Technion - Israel Institute of Technology, Haifa, Israel.
Diego RomeroDepartamento de Microbiología, Instituto de Hortofruticultura Subtropical y Mediterránea 'La Mayora', Universidad de Málaga-Consejo Superior de Investigaciones Científicas (IHSM-UMA-CSIC), Universidad de Málaga, Málaga, Spain.ORCID 0000-0002-2052-6515
Matthew ChapmanDepartment of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, USA.ORCID 0000-0002-2645-1294
Ilana Kolodkin-GalDepartment of Plant Pathology and Microbiology, the Robert H. Smith Faculty of Agriculture, Food & Environment, The Hebrew University of Jerusalem, Rehovot, Israel. ilana.kolodkin@runi.ac.il.ORCID 0000-0002-8464-5660
Serge AnkriDepartment of Molecular Microbiology, Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. sankri@technion.ac.il.
Technion – Israel Institute of Technology · ILConsejo Superior de Investigaciones Científicas · ESUniversity of Michigan · USReichman University · IL

Funding

Molecular Mechanisms of Microbial Pathogenesis Training ProgramT32AI007528 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARRUTHERS, VERNON BRUCE · 1998 to 2024
$6.8M
Israel Science Foundation (ISF) 3208/19NIAID NIH HHS T32 AI007528
6 · The paper itself

Abstract

The human protozoan parasite Entamoeba histolytica is responsible for amebiasis, a disease endemic to developing countries. E. histolytica trophozoites colonize the large intestine, primarily feeding on bacteria. However, in the gastrointestinal tract, bacterial cells form aggregates or structured communities called biofilms too large for phagocytosis. Remarkably, trophozoites are still able to invade and degrade established biofilms, utilizing a mechanism that mimics digestive exophagy. Digestive exophagy refers to the secretion of digestive enzymes that promote the digestion of objects too large for direct phagocytosis by phagocytes. E. histolytica cysteine proteinases (CPs) play a crucial role in the degradation process of Bacillus subtilis biofilm. These proteinases target TasA, a major component of the B. subtilis biofilm matrix, also contributing to the adhesion of the parasite to the biofilm. In addition, they are also involved in the degradation of biofilms formed by Gram-negative and Gram-positive enteric pathogens. Furthermore, biofilms also play an important role in protecting trophozoites against oxidative stress. This specific mechanism suggests that the amoeba has adapted to prey on biofilms, potentially serving as an untapped reservoir for novel therapeutic approaches to treat biofilms. Consistently, products derived from the amoeba have been shown to restore antibiotic sensitivity to biofilm cells. In addition, our findings reveal that probiotic biofilms can act as a protective shield for mammalian cells, hindering the progression of the parasite towards them.

Indexed as

AmoebaEntamoeba histolyticaAnimalsBiofilmsGastrointestinal TractHumansMammalsPhagocytosis

Identifiers

PMID37813896
PMCPMC10562373
OpenAlexW4387452541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.